Retension Pharmaceutical

Falls Church, VA · Founded 2023 · Privately Held (backing)

Developer of therapeutic drugs designed for patients with hypertension. Retension Pharmaceutical is based in Falls Church, VA and was founded in 2023. Its last reported valuation was $50 million in May 2025. It has raised $22.4 million.

Last reported valuation
$50.0M
Oct 2026
Priced at
—
Total raised
$22.4M
Last round
—

Who backs Retension Pharmaceutical?

4 investors
InvestorType
Dais PartnersGrowth equity
Collage Venture Partners—
Green Park & Golf Ventures—
Transhuman Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Retension Pharmaceutical investors

4 investors are on record for Retension Pharmaceutical, including Dais Partners, Collage Venture Partners, Green Park & Golf Ventures and Transhuman Capital.

Free account
More of Retension Pharmaceutical with a free account
  • ·Watch Retension Pharmaceutical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 4 firms already write checks for companies like Retension Pharmaceutical. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View